615 related articles for article (PubMed ID: 26678633)
1. Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trial.
Prati F; Romagnoli E; Limbruno U; Pawlowski T; Fedele S; Gatto L; Di Vito L; Pappalardo A; Ramazzotti V; Picchi A; Trivisonno A; Materia L; Pfiatkosky P; Paoletti G; Marco V; Tavazzi L; Versaci F; Stone GW
Am Heart J; 2015 Dec; 170(6):1116-23. PubMed ID: 26678633
[TBL] [Abstract][Full Text] [Related]
2. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.
Brener SJ; Maehara A; Dizon JM; Fahy M; Witzenbichler B; Parise H; El-Omar M; Dambrink JH; Mehran R; Oldroyd K; Gibson CM; Stone GW
JACC Cardiovasc Interv; 2013 Jul; 6(7):718-24. PubMed ID: 23866184
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of standard versus ClearWay-infused abciximab and thrombectomy in myocardial infarction: rationale and design of the COCTAIL II study.
Prati F; Di Vito L; Ramazzotti V; Imola F; Pawlowski T; Materia L; Tavazzi L; Biondi-Zoccai G; Albertucci M
J Cardiovasc Med (Hagerstown); 2013 May; 14(5):364-71. PubMed ID: 22929568
[TBL] [Abstract][Full Text] [Related]
4. Impact of oral P2Y12 inhibitors on residual thrombus burden and reperfusion indexes in patients with ST-segment elevation myocardial infarction.
Di Vito L; Versaci F; Limbruno U; Pawlowski T; Gatto L; Romagnoli E; Cattabiani MA; Micari A; Trivisonno A; Marco V; Prati F
J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):701-6. PubMed ID: 27467458
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.
Stone GW; Maehara A; Witzenbichler B; Godlewski J; Parise H; Dambrink JH; Ochala A; Carlton TW; Cristea E; Wolff SD; Brener SJ; Chowdhary S; El-Omar M; Neunteufl T; Metzger DC; Karwoski T; Dizon JM; Mehran R; Gibson CM;
JAMA; 2012 May; 307(17):1817-26. PubMed ID: 22447888
[TBL] [Abstract][Full Text] [Related]
6. A comparison of intracoronary treatment strategies for thrombus burden removal during primary percutaneous coronary intervention: a COCTAIL II substudy.
Gatto L; Di Landro A; Romagnoli E; Marco V; Russo C; Pawlowski T; Versaci F; Limbruno U; Castriota F; Di Vito L; Trivisonno A; Prati F
Coron Artery Dis; 2018 May; 29(3):186-193. PubMed ID: 29084042
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary or intravenous abciximab after aspiration thrombectomy in patients with STEMI undergoing primary percutaneous coronary intervention.
Bedjaoui A; Allal K; Lounes MS; Belhadi CE; Mekarnia A; Sediki S; Kara M; Azaza A; Monsuez JJ; Benkhedda S
Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):45-51. PubMed ID: 30460974
[TBL] [Abstract][Full Text] [Related]
8. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study.
Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Gaudreault V; Proulx G; Barbeau G; Déry JP; Gleeton O; Manh-Nguyen C; Noël B; Roy L; Costerousse O; De Larochellière R;
Am J Cardiol; 2010 Jun; 105(11):1520-7. PubMed ID: 20494655
[TBL] [Abstract][Full Text] [Related]
10. Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial.
Brener SJ; Witzenbichler B; Maehara A; Dizon J; Fahy M; El-Omar M; Dambrink JH; Genereux P; Mehran R; Oldroyd K; Parise H; Gibson CM; Stone GW
Am Heart J; 2013 Jul; 166(1):64-70. PubMed ID: 23816023
[TBL] [Abstract][Full Text] [Related]
11. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
[TBL] [Abstract][Full Text] [Related]
12. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R
JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction.
Gibson CM; Maehara A; Lansky AJ; Wohrle J; Stuckey T; Dave R; Cox D; Grines C; Dudek D; Steg G; Parise H; Wolff SD; Cristea E; Stone GW
Am Heart J; 2011 Mar; 161(3):478-486.e7. PubMed ID: 21392601
[TBL] [Abstract][Full Text] [Related]
15. Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial.
Gabriel HM; Oliveira JA; da Silva PC; da Costa JM; da Cunha JA
Catheter Cardiovasc Interv; 2006 Aug; 68(2):218-24. PubMed ID: 16817177
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.
Zeymer U; Margenet A; Haude M; Bode C; Lablanche JM; Heuer H; Schröder R; Kropff S; Bourkaib R; Banik N; Zahn R; Teiger E
J Am Coll Cardiol; 2010 Aug; 56(6):463-9. PubMed ID: 20670755
[TBL] [Abstract][Full Text] [Related]
17. ClearWayRX system to reduce intracoronary thrombus in patients with acute coronary syndromes according to optical coherence tomography after abciximab intracoronary local infusion trial (COCTAIL): study rationale and design.
Capodanno D; Prati F; Pawlowsky T; Ramazzotti V; Albertucci J; La Manna A; Robert G; Tamburino C
J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):130-6. PubMed ID: 19829141
[TBL] [Abstract][Full Text] [Related]
18. The role of residual intrastent thrombus during primary angioplasty: insights from the COCTAIL II study.
Gatto L; Romagnoli E; Versaci F; Limbruno U; Pawlowski T; Porto I; Marco V; Di Vito L; Imola F; Cremonesi A; Prati F
J Cardiovasc Med (Hagerstown); 2017 May; 18(5):348-353. PubMed ID: 28212135
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of early versus late glycoprotein IIb/IIIa inhibitors for PCI.
Xu Q; Yin J; Si LY
Int J Cardiol; 2013 Jan; 162(3):210-9. PubMed ID: 22769575
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Piccolo R; Eitel I; Galasso G; Iversen AZ; Gu YL; Dominguez-Rodriguez A; de Smet BJ; Mahmoud KD; Abreu-Gonzalez P; Thiele H; Piscione F
Vascul Pharmacol; 2015 Oct; 73():32-7. PubMed ID: 26071862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
